Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 24,826–24,850 of 27,380 studies, newest first · page 994 of 1096.

June 2002 13

  1. 2002-06-01

    Association between high-density lipoprotein and cognitive impairment in the oldest old

    ✓ Peer-reviewed Cognitive tests and assessment Annals of neurology

    Key finding: At the same time, cardiovascular disease and stroke are important risk factors for dementia. +3 more findings

  2. 2002-06-01

    Developmental neurobiology of childhood stress and trauma

    ✓ Peer-reviewed Lewy body dementia The Psychiatric clinics of North America

    Key finding: Severe early stress and maltreatment produces a cascade of events that have the potential to alter brain development. +4 more findings

  3. 2002-06-01

    Reduced frontotemporal functional connectivity in schizophrenia associated with auditory hallucinations

    ✓ Peer-reviewed Lewy body dementia Biological psychiatry

    Key finding: Previous demonstrations of hypofrontality in schizophrenia may reflect particular task requirements. +2 more findings

  4. 2002-06-01

    Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters

    ✓ Peer-reviewed Lewy body dementia Journal of neuroscience research

    Key finding: Accumulation of alpha-synuclein has been associated with neurodegenerative disorders, such as Lewy body disease and multiple system atrophy. +4 more findings

  5. 2002-06-01

    Elevated expression of beta-site amyloid precursor protein cleaving enzyme 2 in brains of patients with Down syndrome

    ✓ Peer-reviewed Down syndrome and Alzheimer's Neuroscience letters

    Key finding: The gene encoding the beta-site amyloid precursor protein cleaving enzyme 2 (BACE2) has been determined to be located on the long arm of chromosome 21 at 21q22.3. +4 more findings

  6. 2002-06-01

    The DSCR1 (Adapt78) isoform 1 protein calcipressin 1 inhibits calcineurin and protects against acute calcium-mediated stress damage, including transient oxidative stress

    ✓ Peer-reviewed Down syndrome and Alzheimer's FASEB journal : official publication of the Federation of American Societies for Experimental Biology

    Key finding: Although DSCR1 (Adapt78) has been associated with successful adaptation to oxidative stress and calcium stress and with devastating diseases such as Alzheimer's and Down syndrome, no rationale for these apparently contradictory findings has been tested. +1 more finding

  7. 2002-06-01

    Incidence and prediction of falls in Parkinson's disease: a prospective multidisciplinary study

    ✓ Peer-reviewed How common it is Journal of neurology, neurosurgery, and psychiatry

    Key finding: Falls are a common problem in PD and some of the major risk factors are potentially modifiable. +1 more finding

  8. 2002-06-01

    Dietary intake of antioxidants and risk of Alzheimer disease

    ✓ Peer-reviewed How common it is JAMA

    Key finding: High dietary intake of vitamin C and vitamin E may lower the risk of Alzheimer disease. +3 more findings

  9. 2002-06-01

    How effective are interventions with caregivers? An updated meta-analysis

    ✓ Peer-reviewed Caregiving The Gerontologist

    Key finding: The combined interventions produced a significant improvement of 0.14 to 0.41 standard deviation units, on average, for caregiver burden, depression, subjective well-being, perceived caregiver satisfaction, ability/knowledge, and care receiver symptoms.

  10. 2002-06-01
  11. 2002-06-01
  12. 2002-06-01
  13. 2002-06-01

    Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study

    ✓ Peer-reviewed Genetics JAMA

    Key finding: This study suggests that vitamin E from food, but not other antioxidants, may be associated with a reduced risk of AD. +3 more findings

May 2002 12

  1. 2002-05-21

    Quantifying heterogeneity in a meta‐analysis

    ✓ Peer-reviewed How common it is Statistics in Medicine

    The extent of heterogeneity in a meta-analysis partly determines the difficulty in drawing overall conclusions.

  2. 2002-05 month only

    Nefiracetam. Daiichi Seiyaku

    ✓ Peer-reviewed Clinical trials Current opinion in investigational drugs (London, England : 2000)

    Key finding: By September 1999, nefiracetam was In phase II trials in the US for the treatment of mental symptoms associated with sequelae of stroke and Alzheimer's type dementia.

  3. 2002-05 month only

    Pharmacologic treatments of dementia

    ✓ Peer-reviewed Treatments The Medical clinics of North America

    Key finding: This standard is based on the results of large-scale, double-blind, placebo-controlled trials. +4 more findings

  4. 2002-05-01

    Drebrin, a dendritic spine protein, is manifold decreased in brains of patients with Alzheimer's disease and Down syndrome

    ✓ Peer-reviewed Down syndrome and Alzheimer's Neuroscience letters

    Key finding: We used Western blotting to determine protein levels of drebrin and F-actin in frontal, temporal cortex and cerebellum from patients with DS and AD as compared to controls. +1 more finding

  5. 2002-05-01

    Use of anticholinergic medications by older adults with dementia

    ✓ Peer-reviewed Digital health tools Journal of the American Geriatrics Society

    Key finding: Community-based, commercially insured, older adults with probable dementia are more likely to take anticholinergics than matched controls. +1 more finding

  6. 2002-05-01

    The cost of behavioral and psychological symptoms of dementia (BPSD) in community dwelling Alzheimer's disease patients

    ✓ Peer-reviewed Health systems and care delivery International journal of geriatric psychiatry

    Key finding: Approximately 30% (4115 dollars) of the total annual cost of AD (14420 dollars) is invested in the direct management of BPSD. +1 more finding

  7. 2002-05-01

    Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy

    ✓ Peer-reviewed Disease mechanisms Human molecular genetics

    Key finding: Protein conformational disorders (PCDs), such as Alzheimer's disease, Huntington's disease (HD), Parkinson's disease and oculopharyngeal muscular dystrophy, are associated with proteins that misfold and aggregate. +4 more findings

  8. 2002-05-01

    Air pollution and brain damage

    ✓ Peer-reviewed Risk factors Toxicologic pathology

    Key finding: Exposure to complex mixtures of air pollutants produces inflammation in the upper and lower respiratory tract.

  9. 2002-05-01

    A path model of chronic stress, the metabolic syndrome, and coronary heart disease

    ✓ Peer-reviewed Risk factors Psychosomatic medicine

    Key finding: In older men, pathways occurred from chronic stress to distress to the metabolic syndrome, which in turn predicted CHD.

  10. 2002-05-01

    Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies

    ✓ Peer-reviewed Brain scans and imaging The American journal of psychiatry

    Key finding: Power analyses for voxels showing maximal decline over the 1-year period in regional cerebral glucose metabolism (mg/100 g per minute) were computed to estimate the sample sizes needed to detect a significant treatment response in a 1-year, double-blind, placebo-controlled treatment study. +4 more findings

  11. 2002-05-01

    Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model

    ✓ Peer-reviewed Tau biomarkers Nature neuroscience

    Key finding: We have previously shown that chronic treatment with the monoclonal antibody m266, which is specific for amyloid beta-peptide (Abeta), increases plasma concentrations of Abeta and reduces Abeta burden in the PDAPP transgenic mouse model of Alzheimer's disease (AD). +1 more finding

  12. 2002-05-01

    Seizure-associated hippocampal volume loss: a longitudinal magnetic resonance study of temporal lobe epilepsy

    ✓ Peer-reviewed Hippocampus size on brain scans Annals of neurology

    Key finding: This longitudinal quantitative magnetic resonance imaging study of 24 patients with mild temporal lobe epilepsy shows an ipsilateral hippocampal volume decrease of 9% (range, -30 to +0.5%; p = 0.002, paired t test) over a period of 3.5 +/- 0.7 years. +1 more finding

Browse the library by subject, with the full score breakdown →